Company profile: Wake Research
1.1 - Company Overview
Company description
- Provider of integrated clinical research services through premier investigational sites, including clinical trials evaluating new medical treatments, devices, drugs, and interventions; participant recruitment, qualification, and retention; collection, verification, and preliminary reporting of trial data; and clinical research facilities equipped with advanced testing and research equipment across various therapeutic areas.
Products and services
- Clinical Research Facilities: Research-grade sites equipped with advanced testing and research equipment, enabling conduct of clinical trials across various therapeutic areas with dedicated infrastructure and instrumentation
- Clinical Trials: Integrated, clinical-grade studies that evaluate the safety and effectiveness of new medical treatments, devices, drugs, or interventions conducted across premier investigational sites
- Participant Recruitment: Custom-managed process that recruits, qualifies, and retains volunteers for clinical trials, ensuring a diverse selection of participants aligned with study needs and sustained engagement
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Wake Research
Molecular Neuroimaging
HQ: United States
Website
- Description: Provider of neuroimaging services as a biotechnology firm.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Molecular Neuroimaging company profile →
Cellumen
HQ: United States
Website
- Description: Provider of cellular systems biology solutions delivering accurate predictions of drug efficacy and safety to drive Discovery Toxicology and reduce failure rates and development costs. Offers biomarker analysis tools, including for COVID-19 and cardiac issues, cloning, assay kits (ELISA and protein), and cDNA for research.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cellumen company profile →
Synteract
HQ: United States
Website
- Description: Provider of full-service contract research organization (CRO) solutions focused on emerging biopharma, supporting biotech and pharmaceutical companies across all phases of drug development with multidisciplinary teams and expertise in oncology, dermatology, general medicine, infectious disease and vaccine, and neuroscience; a Syneos Health company.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Synteract company profile →
Casimir
HQ: United States
Website
- Description: Provider of virtual trials and remote assessments and qualitative research centered on the patient experience, capturing the real-world impact of treatment interventions on patient quality-of-life through smart outcome measures.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Casimir company profile →
Senn Chemicals
HQ: Switzerland
Website
- Description: Provider of peptide development and manufacturing services, spanning intermediates to CGMP API and supporting discovery through commercial production. In the peptide business since 1963, SENN offers expertise to optimize processes and streamline scale-up.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Senn Chemicals company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Wake Research
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Wake Research
2.2 - Growth funds investing in similar companies to Wake Research
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Wake Research
4.2 - Public trading comparable groups for Wake Research
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →